의료용 플라스틱 시장 보고서 : 소재별, 용도별, 지역별(2026-2034년)

The global medical plastics market size reached USD 30.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 49.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.13% during 2026-2034.Increasing demand for medical devices and equipment, growing prevalence of chronic diseases, stringent regulatory standards, rising geriatric population, COVID-19 pandemic emphasizing infection prevention, technological advancements, and minimally invasive surgical (MIS) procedures are some of the factors creating a positive outlook for the market.

Medical Plastics Market Trends:

Escalating demand for medical devices

The increasing requirement for medical devices and equipment across the world is a key growth factor for the global medical plastics market.. As health facilities seek to meet the rising patient demand, the demand for plastics-made medical devices grows since they are versatile and relatively affordable and meet stringent regulatory specifications for medical products. From diagnostic equipment to surgical instruments, medical-grade plastics are versatile enough to fit into a variety of applications.

Surging prevalence of chronic diseases

Another major factor contributing to the trend is the rapid rise in chronic conditions, ranging from diabetes and cardiovascular conditions to respiratory disorders. Due to the increasing prevalence of such diseases, medical interventions and therapy are in high demand globally. As a result, various medical equipment, tools, and products made of plastics are needed to support this growing need, which has further surged the demand for medical plastics as they are durable, flexible, and biocompatible, making them perfect for multiple applications in disease control and management.

Stringent regulatory standards

The demand for medical plastics is also driven by the strict regulatory standards on medical devices and products safety and efficacy. Regulatory bodies across the globe provide guidelines for materials used in healthcare applications to ensure that they are of high quality and safe for patient health. Medical grade plastics have properties such as biocompatibility, sterility, and chemical resistance, characteristic of the regulatory requirements. Consequently, as patient safety and infection control receives unprecedented prioritization by healthcare facilities, many prefer medical equipment and devices made of quality plastics that support these priorities.

Medical Plastics Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on material and application.

Breakup by Material:

• Polyvinyl Chloride (PVC)
• Polypropylene (PP)
• Engineering Plastics
• Polyethylene (PE)
• Polystyrene (PS)
• Silicones
• Others

Polyvinyl chloride (PVC) represents the leading market segment

The polyvinyl chloride (PVC) segment in medical plastics is driven by several key factors, such as the increasing demand for cost-effective and versatile materials in medical device manufacturing propels the growth of PVC usage. PVC offers a balance between affordability and performance, making it an attractive choice for a wide range of medical applications such as tubing, intravenous (IV) bags, and blood transfusion sets. Furthermore, the excellent properties of PVC, including flexibility, durability, and chemical resistance, make it suitable for various medical devices and equipment, driving its adoption across healthcare settings. Additionally, stringent regulatory standards mandating the use of safe and sterile materials in medical applications further boost the demand for PVC, as it meets regulatory requirements effectively. Moreover, the versatility of PVC enables manufacturers to produce a wide range of medical products tailored to specific healthcare needs, catering to diverse patient populations and medical procedures. Apart from this, the COVID-19 pandemic has underscored the importance of PVC in healthcare, particularly in the production of essential medical supplies such as PPE kits and medical packaging, further driving its demand.

Breakup by Application:

• Disposables
• Drug Delivery Devices
• Diagnostic Instruments
• Catheters
• Surgical Instruments
• Others

Disposables represents the leading market segment

The disposables segment in medical plastics is driven by several key factors, each influencing its growth trajectory significantly, such as the increasing demand for single-use medical products in healthcare settings fuels the growth of the disposables segment. With the rising emphasis on infection prevention and control, healthcare facilities prioritize the use of disposable medical items to minimize the risk of cross-contamination and nosocomial infections. This heightened focus on patient safety drives the adoption of disposable medical plastics, including syringes, catheters, gloves, and surgical drapes, among others. Secondly, the expanding healthcare infrastructure, particularly in emerging economies, drives the demand for disposable medical plastics. As healthcare access improves and medical facilities expand, there is a growing need for affordable and easily accessible medical supplies, leading to increased consumption of disposable medical products made from plastics. Moreover, the disposables segment is propelled by advancements in manufacturing technologies, such as injection molding and extrusion, which enable cost-effective production of disposable medical plastics at scale.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Asia Pacific leads the market, accounting for the largest medical plastics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for medical plastics.

The Asia Pacific region is driven by the increasing demand for medical devices and equipment, fueled by the region's growing population and rising healthcare needs. With expanding economies and improving healthcare infrastructure, countries in the Asia Pacific are witnessing a surge in demand for medical plastics to support their healthcare systems. Additionally, the prevalence of chronic diseases is on the rise in the region, driving the demand for medical interventions and therapies, thus increasing the need for medical plastics. Furthermore, stringent regulatory standards mandating the use of safe and sterile materials in healthcare settings are influencing the adoption of medical-grade plastics in the Asia Pacific region, ensuring compliance with international quality and safety standards.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the medical plastics industry include Arkema SA, BASF SE, Celanese Corporation, Covestro AG, The Dow Chemical Company, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.), Trinseo PLC, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

• Key players in the medical plastics market are actively engaged in various strategies to maintain and enhance their market positions. These strategies include product innovation and development to meet evolving customer needs and regulatory requirements. Companies are investing significantly in research and development (R&D) activities to introduce novel materials and technologies that offer improved performance, biocompatibility, and cost-effectiveness. Moreover, strategic partnerships, collaborations, and mergers and acquisitions are prevalent among key players, facilitating access to new markets, technologies, and distribution channels. Additionally, market players are focusing on expanding their global presence through geographical expansion and market penetration strategies, targeting emerging economies with growing healthcare infrastructures. Furthermore, sustainability initiatives are gaining traction among key players, with a growing emphasis on developing eco-friendly and recyclable medical plastics to address environmental concerns and align with regulatory trends towards sustainability. Moreover, investments in manufacturing capabilities and supply chain optimization are being made to enhance operational efficiency and meet the increasing demand for medical plastics globally.

Key Questions Answered in This Report

• 1.What was the size of the global medical plastics market in 2025?
• 2.What is the expected growth rate of the global medical plastics market during 2026-2034?
• 3.What has been the impact of COVID-19 on the global medical plastics market?
• 4.What are the key factors driving the global medical plastics market?
• 5.What is the breakup of the global medical plastics market based on the material?
• 6.What is the breakup of the global medical plastics market based on the application?
• 7.What are the key regions in the global medical plastics market?
• 8.Who are the key players/companies in the global medical plastics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Plastics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Material

• 6.1 Polyvinyl Chloride (PVC)
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Polypropylene (PP)
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Engineering Plastics
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Polyethylene (PE)
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Polystyrene (PS)
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Silicones
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Others
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by Application

• 7.1 Disposables
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Drug Delivery Devices
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Diagnostic Instruments
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Catheters
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Surgical Instruments
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Arkema SA
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 BASF SE
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Celanese Corporation
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Covestro AG
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
  • 13.3.5 The Dow Chemical Company
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 DuPont de Nemours Inc
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Evonik Industries AG
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Exxon Mobil Corporation
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
  • 13.3.9 SABIC
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Solvay S.A.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis
  • 13.3.11 The Lubrizol Corporation (Berkshire Hathaway Inc.)
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 SWOT Analysis
  • 13.3.12 Trinseo PLC
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
    • 13.3.12.3 Financials